Effect of raloxifene on aortic elasticity in healthy postmenopausal women

American Heart Journal

Volumn 150, Issue 6, 2005, Pages 1212.e1-1212.e6

  Tritos, Nicholas A ^a   Goepfert, Lois ^a   Kissinger, Kraig V ^a   Katsimaglis, George ^a   Manning, Warren J ^a   Danias, Peter G ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RALOXIFENE;

ABDOMINAL AORTA; ADULT; AGED; AORTA; AORTA WALL; ARTICLE; ASCENDING AORTA; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART EJECTION FRACTION; HEART RATE; HUMAN; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; VISCOELASTICITY; YOUNG MODULUS;

EID: 28844490186     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.02.020     Document Type: Article

References (40)

1. M. Penotti, T. Nencioni, and L. Gabrielli Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy Am J Obstet Gynecol 169 1993 1226 1232
2. B. Cacciatore, I. Paakkari, and J. Toivonen Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow Obstet Gynecol 92 1998 563 568
3. G.D. Giraud, M.J. Morton, and R.A. Wilson Effects of estrogen and progestin on aortic size and compliance in postmenopausal women Am J Obstet Gynecol 174 1996 1708 1717
4. C. Rajkumar, B.A. Kingwell, and J.D. Cameron Hormonal therapy increases arterial compliance in postmenopausal women J Am Coll Cardiol 30 1997 350 356
5. M. Volterrani, G. Rosano, and A. Coats Estrogen acutely increases peripheral blood flow in postmenopausal women Am J Med 99 1995 119 122
6. E. Siris, J.D. Adachi, and Y. Lu Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple outcomes of raloxifene evaluation Osteoporos Int 13 2002 907 913
7. M.W. Draper The role of selective estrogen receptor modulators (SERMs) in postmenopausal health Ann N Y Acad Sci 997 2003 373 377
8. P.M. Sarrel, H. Nawaz, and W. Chan Raloxifene and endothelial function in healthy postmenopausal women Am J Obstet Gynecol 188 2003 304 309
9. A. Saitta, N. Morabito, and N. Frisina Cardiovascular effects of raloxifene hydrochloride Cardiovasc Drug Rev 19 2001 57 74
10. N.H. Bjarnason, J. Haarbo, and I. Byrjalsen Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits Circulation 96 1997 1964 1969
11. P.D. Delmas, N.H. Bjarnason, and B.H. Mitlak Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women N Engl J Med 337 1997 1641 1647
12. B.W. Walsh, L.H. Kuller, and R.A. Wild Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women JAMA 279 1998 1445 1451
13. B.W. Walsh, S. Paul, and R.A. Wild The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial J Clin Endocrinol Metab 85 2000 214 218
14. L.M. Resnick, D. Militianu, and A.J. Cunnings Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium Hypertension 30 1997 654 659
15. M. Groenink, A. de Roos, and B.J. Mulder Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome Am J Cardiol 82 1998 203 208
16. T. Porro, F. Colombo, and F.L. Azzola Diurnal blood pressure variability in essential hypertension and vascular reactivity to isometric stress J Hum Hypertens 9 1995 329 335
17. T. Weber, J. Auer, and M.F. O'Rourke Arterial stiffness, wave reflections, and the risk of coronary artery disease Circulation 109 2004 184 189
18. C. Stefanadis, J. Dernellis, and E. Tsiamis Aortic stiffness as a risk factor for recurrent acute coronary events in patients with ischaemic heart disease Eur Heart J 21 2000 390 396
19. E.D. Lehmann, K.D. Hopkins, and A. Rawesh Relation between number of cardiovascular risk factors/events and noninvasive Doppler ultrasound assessments of aortic compliance Hypertension 32 1998 565 569
20. M.A. Tedesco, F. Natale, and G. Di Salvo Effects of coexisting hypertension and type II diabetes mellitus on arterial stiffness J Hum Hypertens 18 2004 469 473
21. J.L. Megnien, A. Simon, and P. Valensi Comparative effects of diabetes mellitus and hypertension on physical properties of human large arteries J Am Coll Cardiol 20 1992 1562 1568
22. S. Laurent, P. Boutouyrie, and R. Asmar Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients Hypertension 37 2001 1236 1241
23. J. Blacher, R. Asmar, and S. Djane Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients Hypertension 33 1999 1111 1117
24. A. Mahmud, and J. Feely Effect of smoking on arterial stiffness and pulse pressure amplification Hypertension 41 2003 183 187
25. G.M. London, S.J. Marchais, and A.P. Guerin Arterial stiffness and function in end-stage renal disease Adv Chronic Kidney Dis 11 2004 202 209
26. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
27. N.H. Bjarnason, J. Haarbo, and I. Byrjalsen Raloxifene and estrogen reduces progression of advanced atherosclerosis-a study in ovariectomized, cholesterol-fed rabbits Atherosclerosis 154 2001 97 102
28. R.F. Kauffman, J.S. Bean, and K.J. Fahey Raloxifene and estrogen inhibit neointimal thickening after balloon injury in the carotid artery of male and ovariectomized female rats J Cardiovasc Pharmacol 36 2000 459 465
29. N.H. Bjarnason, J. Haarbo, and I. Byrjalsen Raloxifene reduces atherosclerosis: studies of optimized raloxifene doses in ovariectomized, cholesterol-fed rabbits Clin Endocrinol (Oxf) 52 2000 225 233
30. A. Mori-Abe, S. Tsutsumi, and K. Takahashi Estrogen and raloxifene induce apoptosis by activating p38 mitogen-activated protein kinase cascade in synthetic vascular smooth muscle cells J Endocrinol 178 2003 417 426
31. K. Takahashi, M. Ohmichi, and M. Yoshida Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells J Endocrinol 178 2003 319 329
32. M.F. O'Rourke, J.A. Staessen, and C. Vlachopoulos Clinical applications of arterial stiffness; definitions and reference values Am J Hypertens 15 2002 426 444
33. K. Et-Taouil, M. Safar, and G.E. Plante Mechanisms and consequences of large artery rigidity Can J Physiol Pharmacol 81 2003 205 211
34. I. Kallikazaros, C. Tsioufis, and P. Zambaras Conjugated estrogen administration improves common carotid artery elastic properties in normotensive postmenopausal women Clin Cardiol 25 2002 167 172
35. S. Miura, E. Tanaka, and A. Mori Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women Maturitas 45 2003 293 298
36. S. Gorgulu, M. Eren, and S. Celik The effects of hormonal therapy on aortic stiffness and left ventricular diastolic function Acta Cardiol 58 2003 1 8
37. K.A. Rodriguez-Macias, T. Naessen, and A. Bostrom Arterial stiffness is not improved in long-term use of estrogen Am J Obstet Gynecol 186 2002 189 194
38. E.D. Lehmann, J.R. Ross, and R.G. Gosling Effect of hormone replacement therapy on aortic compliance in postmenopausal women Am J Obstet Gynecol 177 1997 1272 1273
39. C. Stefanadis, E. Tsiamis, and J. Dernellis Effect of estrogen on aortic function in postmenopausal women Am J Physiol 276 1999 H658 H662
40. S.Y. Honisett, B. Pang, and L. Stojanovska Progesterone does not influence vascular function in postmenopausal women J Hypertens 21 2003 1145 1149